| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Flurazepam | LP16153-6 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Vitr fld | LP7715-8 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Flurazepam | Vitreous fluid | Drug toxicology | LP391692-3 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ng/mL | |
| EXAMPLE_UCUM_UNITS | ng/mL | |
| UNITSREQUIRED | Y |
| LONG_COMMON_NAME | en-US | Flurazepam [Mass/volume] in Vitreous fluid |
| LONG_COMMON_NAME | en-US | Flurazepam [Mass/volume] in Vitreous fluid |
| SHORTNAME | en-US | Flurazepam Vitf-mCnc |
| ConsumerName | en-US | Flurazepam, Vitreous fluid |
| SHORTNAME | es-AR | flurazepam:concentración de masa:punto en el tiempo:líquido vítreo:cuantitativo: |
| SHORTNAME | pt-BR | Flurazepam Vitf-mCnc |
| LONG_COMMON_NAME | fr-FR | Flurazépam [Masse/Volume] Liquide vitrée ; Numérique |
| LONG_COMMON_NAME | nl-NL | Flurazepam [massa/volume] in glasachtig vocht |
| LONG_COMMON_NAME | es-MX | Flurazepam: Líquido vítreo : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77
FHIR